Back to search
Chronic Active Epstein-Barr Virus
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Active Epstein-Barr Virus trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Active Epstein-Barr Virus trials you may qualify forEpstein-Barr virus (EBV) is a member of the human herpes virus family that infects more than 95 percent of the U.S. population. Most infections occur in childho…
This clinical trial is designed as a single-arm, two-center, open-label, prospective study. All participants are enrolled in the standard-dose unrelated umbilic…
This is a Phase 1/1b, nonrandomized, open-label, parallel assignment, dose-escalation, and dose-expansion study to evaluate the safety and clinical activity of…
This study is a multicenter, prospective, single-arm clinical investigation, with patients with CAEBVD as the main research subjects, to evaluate the effectiven…
The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the inform…
The subject has a type of cancer or lymph gland disease associated with a virus called Epstein Barr Virus (EBV), which has come back, is at risk of coming back,…
Patients with medical conditions requiring allogeneic hematopoietic cell transplantation (allo-HCT) are at risk of developing a condition called graft versus ho…
Patients are being asked to participate in this study because they will be receiving a stem cell transplant as treatment for their disease. As part of the stem…